Sort
261,768 grants matching “gene therapy”
IntellipulseTM Platform Technology for Effective Delivery of Therapeutic Agents
$984,830Gary Strange · Ef Therapeutics Corp. · R44 · FY2025 · CA
PIXUL-FFPE: High throughput platform for chromatin and DNA sample preparation from formalin fixed paraffin embedded (FFPE) tissue samples.
$984,799Karol Bomsztyk · Matchstick Technologies, Inc. · R42 · FY2021 · HG
Reprogramming hematopoietic stem cell (HSC) differentiation via metabolic condit
$984,739Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$984,739Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A platform for high-throughput production of targeting systems for cell-type-specific transgene expression in wild-type animals
$984,588Ian R Wickersham · Massachusetts Institute Of Technology · R01 · FY2017 · MH
Immunobiology and Immunotherapy of Pediatric Tumors
$984,566Crystal L. Mackall · Clinical Sciences · Z01 · FY2007 · CA
Biology and Therapy of T Cell Depletion
$984,566Crystal L Mackall · Clinical Sciences · Z01 · FY2007 · CA
Foundational tools to study the impacts of sympathetic activity on the neuroanatomy and function of brown adipose tissue
$984,472Lori M Zeltser · Columbia University Health Sciences · OT2 · FY2017 · OD
Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
$984,435Martha Or Marty L Slattery · University Of Utah · R01 · FY2008 · CA
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$984,409Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2020 · CA
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
$984,405Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2024 · AI
Mechanistic Signatures of Drug Responses in Cancer
$984,353Timothy J Mitchison · Harvard Medical School · RC2 · FY2010 · HG
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$984,329Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
$984,242Rebecca L Berdeaux · Cellchorus Inc. · R44 · FY2025 · TR
A new approach to monitoring glycosylation during glycoprotein production
$984,227Loretta Yang · Lectenz Bio, Inc. · R44 · FY2024 · GM
The role of clonal hematopoiesis in the development and therapy of myeloid malignancies
$984,165Benjamin Levine Ebert · Dana-Farber Cancer Inst · R35 · FY2023 · CA
The role of clonal hematopoiesis in the development and therapy of myeloid malignancies
$984,165Benjamin Levine Ebert · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$984,084Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Research Project 1
$984,021Erika Augustine · Hugo W. Moser Res Inst Kennedy Krieger · U54 · FY2025 · HD
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
$984,000Rishi Arora · University Of Chicago · R35 · FY2025 · HL
Human and mouse transcriptome profiling identifies cross-species homology of mononuclear phagocytes
$984,000Claudia V Jakubzick · Dartmouth College · R35 · FY2025 · HL
Human and mouse transcriptome profiling identifies cross-species homology of mononuclear phagocytes
$984,000Claudia V Jakubzick · Dartmouth College · R35 · FY2021 · HL
Precision Engineering of STING-DC Immunity to Overcome Tumor Immune Evasion
$984,000Jinming Gao · Ut Southwestern Medical Center · R35 · FY2024 · CA
Human and mouse transcriptome profiling identifies cross-species homology of mononuclear phagocytes
$984,000Claudia V Jakubzick · Dartmouth College · R35 · FY2022 · HL
Precision Engineering of STING-DC Immunity to Overcome Tumor Immune Evasion
$984,000Jinming Gao · Ut Southwestern Medical Center · R35 · FY2025 · CA